Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

29.58
+0.74002.57%
Post-market: 29.690.1100+0.37%19:59 EDT
Volume:8.31M
Turnover:244.18M
Market Cap:6.90B
PE:-47.48
High:29.79
Open:28.67
Low:28.63
Close:28.84
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:212.45M
Volume Ratio:0.70
T/O Rate:3.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:21.30
PE(LYR):57.74

Loading ...

Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says

THOMSON REUTERS
·
Aug 11

Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss

Dow Jones
·
Aug 11

Hims & Hers Shares Drop After Mixed Q2 Earnings — Details

Benzinga Earnings
·
Aug 11

Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth

Reuters
·
Aug 11

Movement Alert|Hims & Hers Health Inc. Falls 5.51% in After-Hours Trading, Q2 EPS Misses Estimate by Wide Margin

Market Focus
·
Aug 11

Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss

MT Newswires Live
·
Aug 11

Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million

Reuters
·
Aug 11

Hims & Hers Health Inc: Making a Multi-Year Commitment to Invest in AI

THOMSON REUTERS
·
Aug 11

Hims & Hers Health Inc: Expect AI Investment to Pay for Itself Within 12 to 18 Months, Expect it to Make Offerings More Affordable for Customers

THOMSON REUTERS
·
Aug 11

Hims & Hers Posts Higher Quarterly Revenue on Strong Subscriber Growth

Reuters
·
Aug 11

Hims & Hers Health Q2 EPS $(0.37) Misses Estimate, Sales $753.214M Beat $699.889M Estimate

Benzinga Earnings
·
Aug 11

Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 3% at $33

THOMSON REUTERS
·
Aug 11

Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million

Reuters
·
Aug 11

Hims & Hers Health Q2 EPS USD -0.37

THOMSON REUTERS
·
Aug 11

Hims & Hers Health, Inc. Q3 REV View $793.1 Mln

THOMSON REUTERS
·
Aug 11

Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda

THOMSON REUTERS
·
Aug 11

Hims & Hers Health: Expect Our Domestic Business to Continue Accelerating Through the Second Half of the Year

THOMSON REUTERS
·
Aug 11

U.S. Earnings Preview: After Market Close Aug. 10

Dow Jones
·
Aug 11

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
Aug 10

Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
·
Aug 10